Tranexid 10% injection

Dexa Medica

Ingredients in every 5 ml

Tranexamic acid 500 mg

Each package contains

10 ampoules of 5 ml

Other details

Dosage form:Injection
Flavour: None

W.H.O. classification

ATC Level 1: B - Blood and blood forming organs
ATC Level 2: B02 - Antihemorrhagics
ATC Level 3: B02A - Antifibrinolytics

Warnings

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Available in

Indonesia

Dosage information

LOCAL FIBRINOLYSIS
Hereditary angioneurotic edema, 500-1000 mg tranexamic acid by slow intravenous injection (maximum 100 mg/min; 2 ml/min for Tranexid 250 mg/5 ml; 1 ml/min for Tranexid 500 mg/5 ml) 3 times daily. For the treatment more than 3 days, it should be considered to use an oral tranexamic acid.

POSTSURGICAL HEMORRHAGE
1 gram 3 times daily, slow intravenous injection, administered for the first 3 days. Therapy is then continued, using 1 gram tranexamic acid orally 3-4 times daily (starts on the fourth day after surgery until macroscopic hematuria is no longer present).

TOOTH EXTRACTION IN PATIENTS WITH HEMOPHILIA
– Immediately before tooth extraction: intravenous, 10 mg/kg of body weight.
– Postsurgical: 25 mg/kg of body weight (orally) 3-4 times daily for 2-8 days.
(for patient unable to take medication orally, intravenous therapy, 10 mg/kg of body weight, 3-4 daily).

PATIENTS WITH RENAL FUNCTION DISORDERS
– Serum creatinine 120-250 micromol/l (1.36-2.83 mg/dl):
IV Dose 10 mg/kg, 2 times daily

– Serum creatinine 250-500 micromol/l (2.83-5.66 mg/dl):
IV Dose 10 mg/kg, once daily

– Serum creatinine >500 micromol/l (>5.66 mg/dl):
IV Dose 10 mg/kg, every 48 hours or 5 mg/kg every 24 hours

Indication

– Fibrinolysis in menorrhagia, epistaxis, traumatic hyphema, neoplasma, obstetric complications, and other surgical procedures including bladder surgery, prostatectomy or conization of the cervix.
– Tooth extraction in patients with hemophilia and prophylactic treatment of hereditary angioedema.

Disclaimer

The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.